Victory Capital Management
ZSAN

Victory Capital Management’s Zosano Pharma Corporation ZSAN Stock Holding History

Victory Capital Management’s Portfolio ZSAN Stock Details ZSAN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-487
Closed -$8K – 2859
2021
Q4 		$8K Sell
487
-3
-0.6% -$63 ﹤0.01% 2743
2021
Q3 		$12K Buy
490
+14
+3% +$363 ﹤0.01% 2754
2021
Q2 		$16K Buy
476
+7
+1% +$226 ﹤0.01% 2718
2021
Q1 		$20K Buy
469
+91
+24% +$3.81K ﹤0.01% 2718
2020
Q4 		$7K Buy
378
+20
+6% +$391 ﹤0.01% 2525
2020
Q3 		$20K Buy
+358
New +$16.7K ﹤0.01% 2436
2020
Q2 		– Sell
-264
Closed -$5K – 3571
2020
Q1 		$5K Buy
+264
New +$8.85K ﹤0.01% 3312
2019
Q4 		– Sell
-87
Closed -$5K – 3555
2019
Q3 		$5K Buy
+87
New +$7.8K ﹤0.01% 3477
2018
Q1 		– Sell
-368
Closed -$134K – 1947
2017
Q4 		$134K Buy
368
+28
+8% +$14.1K ﹤0.01% 1657
2017
Q3 		$196K Buy
340
+4
+1% +$2.93K ﹤0.01% 1535
2017
Q2 		$331K Sell
336
-2
-0.6% -$2.06K ﹤0.01% 1359
2017
Q1 		$449K Buy
+338
New +$408K ﹤0.01% 1324

Other funds holding ZSAN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CDIA
Capital Directions Investment Advisors Atlanta, Georgia $268M AUM 20.15% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return

Victory Capital Management's ZSAN Position: Q1 2022 in Review

Victory Capital Management sold out of Zosano Pharma Corporation (ZSAN) in Q1 2022, closing a stake of 487 shares — an estimated $8K sold.

Victory Capital Management first reported a position in ZSAN in Q1 2017 and held it in 12 quarters. The position peaked at $449K in Q1 2017. 30 funds tracked by Wall St. Rank hold ZSAN as of Q1 2022.

  • Victory Capital Management reported no remaining Zosano Pharma Corporation position as of Q1 2022 after selling out during the quarter.
  • Victory Capital Management sold 487 Zosano Pharma Corporation shares in Q1 2022, an estimated $8K.
  • Victory Capital Management first reported a position in Zosano Pharma Corporation in Q1 2017 and held it in 12 quarters.
  • Victory Capital Management's Zosano Pharma Corporation position peaked at $449K in Q1 2017.
  • 30 funds tracked by Wall St. Rank held Zosano Pharma Corporation as of Q1 2022.

Based on Victory Capital Management's 13F filing for Q1 2022, filed 4 May 2022.